CIK 0001035354 · Non-accelerated filer<br>Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841368850
- Phone
- 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- S-1 Offering Registration Statement
- 10-Q Report Quarterly Report
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Shareholder vote results
- PRE 14C Other PRE 14C
- DRS Other Draft Registration Statement
- 10-K Report Annual Report
- NT 10-Q Other NT 10-Q
- 8-K Event Executive or director change
- NT 10-Q Other NT 10-Q
- NT 10-K Other NT 10-K
- SEC STAFF ACTION Other SEC Staff Action
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- NT 10-Q Other NT 10-Q
Page 3 of 68 · 1,360 filings